A carregar...

SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer

Practical experience with cancer vaccines combined with accumulated knowledge of the complex interactions between cancer and immune system rationalize the combinatorial use of immune adjuvants for better efficacy. We recently described a novel adjuvant system based on the costimulatory SA-4-1BBL and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Srivastava, Abhishek K., Yolcu, Esma S., Dinc, Gunes, Sharma, Rajesh K., Shirwan, Haval
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760279/
https://ncbi.nlm.nih.gov/pubmed/26942082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1064580
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!